Conor P. Cahill

Client-based authentication technology: user-centric authentication using secure containers

Jason Martin, Matthew W. Pagano, Anand Rajan, 2011, DIM '11.

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area

Conor P. Cahill, M. Demoitié, L. Otieno, 2009, PloS one.

Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults

Conor P. Cahill, H. Schuitemaker, G. Leroux-Roels, 2020, Human vaccines & immunotherapeutics.

The taxonomy and aspects of the ecology of the Ephemeroidea (Insecta: Ephemeroptera) of the Mooi River, KwaZulu-Natal Province, Republic of South Africa.

Conor P. Cahill, 2013 .

Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial

Conor P. Cahill, J. Sacarlal, J. Aponte, 2007, Trials.

Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age

Conor P. Cahill, H. Schuitemaker, J. Jacquet, 2022, Human vaccines & immunotherapeutics.

Two decades of commitment to malaria vaccine development: GlaxoSmithKline Biologicals.

Conor P. Cahill, W. Ballou, W. Ballou, 2007, The American journal of tropical medicine and hygiene.

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

Conor P. Cahill, E. Macete, S. Abdulla, 2011, Malaria Journal.

A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine

Conor P. Cahill, H. Schuitemaker, L. van der Fits, 2021, Annals of Internal Medicine.